Weight loss pill could arrive by Christmas | 7NEWS

By 7NEWS Australia

Community Score: 50% | 1.4K views | 1w

0 community ratings: null thumbs up, null thumbs down

Danish pharmaceutical company Novo Nordisk is seeking regulatory approval from the TGA for a pill version of the weight loss injection Wegovy, with a decision expected by Christmas. The once-a-day oral medication contains semaglutide, a GLP-1 peptide that suppresses appetite, and would be the first approved oral GLP-1 peptide for chronic weight management in Australia. With two in three Australian adults and one in four school-aged children now overweight or obese, doctors emphasise the need for more treatment options to intervene early and prevent weight-related health conditions. Subscribe and set 🔔 » https://7news.link/YTSubscribe | For the latest Australian news and breaking news alerts, connect with 7NEWS online: Visit » https://7news.com.au 7Plus » https://7plus.com.au/ 7NEWS Podcast » https://open.spotify.com/user/dm9fk9hzoe68ibpttheragdgi Facebook » https://www.facebook.com/7NewsAustralia TikTok » https://www.tiktok.com/@7newsaustralia Instagram » https://www.instagram.com/

Tags: 7NEWS, 7NEWS Australia, 7newsaustralia, News, Novo Nordisk, TGA approval, Wegovy, australia, breaking news, channel 7, latest news, latest news today, news australia, obesity treatment, seven news, weight loss